Publications by authors named "Duncan Richards"

Claim this Profile
R
REMOVED: Ivermectin and COVID-19.
Christopher C Butler, F D Richard Hobbs, Paul Little, Duncan Richards, Benjamin R Saville

J Infect· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removal notice to "Ivermectin and COVID-19" Journal of Infection 91 (2025) 106530.
Christopher C Butler, F D Richard Hobbs, Paul Little, Duncan Richards, Benjamin R Saville

J Infect· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.
Philip G Drennan, Nicholas M Provine, Stephanie A Harris, Ashley Otter, Kate Hollett, Duncan Richards

Lancet Microbe· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial.
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, Najib M Rahman, Duncan B Richards

Lancet Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing generic clinical trial animated explainer videos in the UK: results of a survey and case study.
Clare Calvert, Vicki S Barber, Duncan Appelbe, Kirsty Sprange, Claire Nollett, Duncan B Richards

Trials· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
Fd Richard Hobbs, Oghenekome A Gbinigie-Thompson, Milensu Shanyinde, Ly-Mee Yu, Victoria Harris, Duncan Richards

J Infect· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial.
May Ee Png, Victoria Harris, Jenna Grabey, Nigel D Hart, Bhautesh D Jani, Duncan B Richards

Br J Gen Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2.
Helen E Higham, Lauren Morgan, Cushla Cooper, Julia Marshall, Andrew Mawer, Duncan Richards

Br J Clin Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.
Leticia Kawano-Dourado, Tejaswini Kulkarni, Christopher J Ryerson, Pilar Rivera-Ortega, Bruno Guedes Baldi, Duncan Richards

Thorax· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study.
Samantha Brady, Andrew Mott, Katie Carlisle, Abhishek Abhishek, Joy Adamson, Duncan Richards

BMJ Open· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
Gail Hayward, Ly-Mee Yu, Paul Little, Oghenekome Gbinigie, Milensu Shanyinde, Duncan Richards

J Infect· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of oxygen-loaded nanobubbles to improve tissue oxygenation: Bone-relevant mechanisms of action and effects on osteoclast differentiation.
Helen J Knowles, Alexandra Vasilyeva, Mihir Sheth, Oliver Pattinson, Jonathan May, Duncan B Richards

Biomaterials· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current usage of explainer animations in trials: a survey of the UKCRC registered clinical trial units in the UK.
Vicki S Barber, Clare Calvert, Duncan Appelbe, Kirsty Sprange, Claire Nollett, Duncan B Richards

Trials· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Duncan B Richards

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.
Praveen Weeratunga, Laura Denney, Joshua A Bull, Emmanouela Repapi, Martin Sergeant, Duncan Richards

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.
Alexander Ooms, Hussein Al-Mossawi, Louise Bennett, Mimi Bogale, Paul Bowness, Duncan Richards

BMJ Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, Jienchi Dorward, Melissa Dobson, Duncan Richards

BMJ Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review.
Philip G Drennan, Dimitrios Karponis, Duncan Richards, Mark Coles, James N Fullerton

Clin Transl Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, Najib M Rahman, Gail Hayward, Duncan B Richards

Lancet· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive validity in drug discovery: what it is, why it matters and how to improve it.
Jack W Scannell, James Bosley, John A Hickman, Gerard R Dawson, Hubert Truebel, Duncan Richards

Nat Rev Drug Discov· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial.
Jienchi Dorward, Ly-Mee Yu, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, Duncan Richards

Br J Gen Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.
Duncan Richards, Helen Millns, Louise Cookson, Mary Ann Lukas

Orphanet J Rare Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes' [Surgery 171 (2021) 77-87].
Omair A Shariq, Kate E Lines, Katherine A English, Bahram Jafar-Mohammadi, Philippa Prentice, Duncan Richards

Surgery· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 therapeutics: Challenges and directions for the future.
Philip C Robinson, David F L Liew, Helen L Tanner, John R Grainger, Raymond A Dwek, Duncan Richards

Proc Natl Acad Sci U S A· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis